RSS

BCAP Baron Capital Enterprise, INC.

Last Post: 09/12/24
Followers: 102
Posts Today: 0
Views Today: 3534

BCAP Stock Quote & Tools

$0.0000 ▲ +0.0000 (+0.00%) As of Sep 23, 9:30 AM EDT
Last0.0000
$ Chg0.0000
Open—
High—
Beta-222.2700
Year High0.000
Market Cap3.7K
P/B Ratio—
EPS—
Avg Vol (30d)88.6K
Volume0
% Chg+0.00%
Prev Close0.0000
Low—
VWAP0.00000
Year Low0.000
Total Shares—
Shares Out3.69B
Float3.69B
ExchangeOTCID
Finance Credit Finance

BCAP Stock Message Board Discussion

  1. equijohn
  2. Pink Lady

Top 10 Most Recent News Articles

Zika Virus: A Surprising Ally in Brain Cancer Fight

Updated Category News Views 0

Here’s something you don’t hear every day: using a virus that typically targets the brain not as a foe, but as a formidable ally in the war against glioblastoma. It’s a gutsy play by UP Oncolytics, a scrappy biotech outfit cradled within Rosalind Franklin University’s Helix 51 incubator. Risky Bet on a Known Adversary Glioblastoma—a real beast in the cancer...

Continue Reading
Firmable's Tech Intelligence: New Edge in B2B Sales

Updated Category News Views 0

New Era for B2B Sales Teams Once again, the B2B sales landscape is getting a jolt—especially for those who’ve been fumbling in the dark pitching to prospects without any real idea of their tech environment. With the introduction of Firmable's Tech Intelligence, those blind days just got a lot brighter. By offering detailed insights into what technologies a company is...

Continue Reading
ASTS Fraud Lawsuit: Investors' Chance to Step Up

Updated Category News Views 1

Investors Grapple with AST SpaceMobile's Legal Challenges When I hear 'securities fraud lawsuit,' my gut instinct as a trader is to dig deep into the grime and figure out what's lurking beneath. AST SpaceMobile, those folks aiming to shake up the satellite game, have some explaining to do. If you've been holding onto ASTS shares between March 4, 2025, and July 15, 2026,...

Continue Reading
eGlint's Rapid Tech Revolutionizes Proteomics with Win

Updated Category News Views 2

A Game-Changer in Proteomics Now ain't this something—eGlint just scooped up the 2026 BioTools Innovator Grand Prize, waving a big ol' $250,000 check around and claiming the biotech spotlight with their swift-moving ProteoNex™ platform. Forget about sticking samples through sluggish labs and waiting an eternity; eGlint's tech is flipping the switch, serving up protein...

Continue Reading
AppLovin Faces Securities Fraud Lawsuit Amid AI Claims

Updated Category News Views 0

Digging Into AppLovin's Legal Turmoil Well, it's another wrinkle in the markets' many lines. This time, we’ve got AppLovin Corporation facing the music with a securities fraud lawsuit. If you’ve got shares in NASDAQ:APP, you might want to perk up. Let the trial by fire begin, I say. The Lawsuit Details & Class Period Here we are, October 19, 2026, and the legal eagles...

Continue Reading
Angels on Call Sets Benchmark for Specialized Homecare

Updated Category News Views 13

Pioneering a New Standard in Homecare Take a gander at Angels on Call Homecare. They're not just another name in a crowded field; they've carved out a niche—specializing in elite care for Dementia and Parkinson's patients. You don't usually hear homecare and innovation in the same breath, do you? But these folks are setting a fresh benchmark. Independent feedback has...

Continue Reading
VISTAR Oakland Workers Join Teamsters for Unity

Updated Category News Views 1

Warehouse Workers Break Free from the Shackles Ever had that feeling, where enough is enough? That's where 37 warehouse workers at VISTAR find themselves, shaking off the dust and signing up with Teamsters Local 853. This ain't just a fleeting wind of change; it's the whole damn storm. Turning Points and Union Victories Think about it. This move by the VISTAR warehouse...

Continue Reading
Coastal Financial Faces Lawsuit Over Fraud Allegations

Updated Category News Views 0

Coastal Financial Corporation, riding high on NASDAQ as CCB, now finds itself in the middle of a storm. Schall, Brown & Schwartz LLP, a firm known for its shareholder rights litigation, has thrown the gauntlet with a class action lawsuit against Coastal for suspected securities violations. We're talking about potential fibs under Section 10(b) and 20(a) of the Securities...

Continue Reading
U.S. Millionaire Surge: Market Waves or Mirage?

Updated Category News Views 3

Flashing Billions: Minting Millionaires at Breakneck Speed It sounds like something out of an 80s movie: every single day, over 1,200 folks in the United States become millionaires. Yep, you heard right. The UBS Global Wealth Report 2026 threw that number out, and it sure caught my attention. It's not everyday you hear about the U.S. cranking out millionaires like they're...

Continue Reading
New Chapter Recovery Garners Key Accreditations

Updated Category News Views 7

Accreditations That Matter It's not every day a treatment facility pops its head up with credentials that weigh like a ton of bricks. New Chapter Recovery in New Jersey just snagged two heavy hitters: Joint Commission accreditation and LegitScript certification. These badges don’t just glimmer for show; they’re the market's assurance against empty promises—an...

Continue Reading

Top 5 Most Recently Viewed Articles

NNIT A/S Faces Hurdles in Q3 2024; Strategies Set for Recovery

Updated Category News Views 77

Understanding NNIT A/S Performance in Q3 2024 NNIT A/S has reported its third quarter financial performance, which unfortunately fell short of expectations. Despite achieving some positive results earlier in the year, the recent figures reveal that growth has stagnated, particularly in the US and European regions. The company recorded a negative organic growth rate of...

Continue Reading
Pharming Group Prepares for Growth: An Insightful Analysis

Updated Category News Views 61

Pharming Group's Growth Trajectory H.C. Wainwright has recently reiterated a positive outlook for Pharming Group (NASDAQ: PHAR), maintaining a Buy rating alongside a $37.00 price target for the stock. This confidence stems from the promising growth prospects within the Hereditary Angioedema (HAE) market, currently valued at around $2.9 billion and expected to surge to...

Continue Reading
Secure Your Family's Legacy at Holy Name Cemetery Open House

Updated Category News Views 106

Final Open House Event at Holy Name Cemetery As the year comes to an end, Holy Name Cemetery & Mausoleum invites families to its last open house event of 2024. This is an excellent chance to make important plans for your family's future and secure peace of mind. Event Details and Activities The open house is scheduled for a special weekend, featuring a unique availability...

Continue Reading
Innovative Partners Transform Stablecoin Payments for Retail

Updated Category News Views 265

Advancing Stablecoin Payments in Luxury Retail Starlynk, Changer.ae, and Quantoz are collaborating to redefine the landscape of global transactions. Their recent agreements aim to expand blockchain-based payment solutions specifically for retail and corporate clients, leveraging stablecoins across various markets. Strategic Collaborations for Expansion The partnerships...

Continue Reading
Tiny Machine Learning Market Growth Insights into 2030

Updated Category News Views 162

Understanding the Tiny Machine Learning Market The Tiny Machine Learning (TinyML) market is set for remarkable growth, with estimates projecting it will reach USD 3.48 billion by 2030. As businesses and industries turn to more intelligent, efficient machine learning solutions that can operate directly on edge devices, the significance of this market is increasingly...

Continue Reading